The Range

Dense Monophasic HA Fillers

Soft texture without compromising shape retention.

Revelina offers three cross-linked HA fillers for aesthetic correction across the face — FINE, DEEP, and SUB-Q — formulated from non-animal origin, dense monophasic hyaluronic acid. Each line is matched to a placement depth and indication, from superficial fine lines to deep, structural volume.

FINE

30G · Superficial dermis

Fine lines and subtle volume — uniform particle distribution for superficial placement.

DEEP

27G · Mid-to-deep dermis

Mid-volume and contour — mid-dermal placement for fuller, defined structure.

SUB-Q

25G · Deep / subcutaneous

Structural lift and high-volume augmentation — deep placement for lasting definition.

Sterile, pyrogen-free viscoelastic gel of cross-linked non-animal origin HA. With Lidocaine. 1.0 mL pre-filled glass syringe.

Why Revelina

Four points of difference

Material and handling characteristics that define every Revelina line.

01

Ultra-Low BDDE

MCO™ Technology minimises residual cross-linking agent.

02

Constant Injection Force

Uniform particles for a consistent, controlled extrusion feel.

03

Dense Monophasic

A homogeneous gel — soft on delivery, stable in shape. Not a particulate biphasic filler.

04

Optimized Viscoelasticity

Stable cross-linking for predictable handling.

Benefits

What Revelina delivers

The clinical and handling benefits that carry across every line.

Long-lasting effect

Stable cross-linking sustains correction over time.

Suitable for sensitive skin

Non-animal origin HA with ultra-low residual BDDE.

Improvement of complexion

Restores hydration and surface smoothness.

Short recovery period

Minimal downtime after a controlled procedure.

Correction at every depth

FINE, DEEP and SUB-Q cover fine lines to deep volume.

Comfortable injection

Formulated with lidocaine for a comfortable injection.

Even distribution of HA gel

Dense monophasic gel spreads uniformly under the skin.

Optimal HA concentration

24 mg/mL balanced for lift and a natural feel.

Low irritation profile

Purified, sterile, pyrogen-free formulation.

Illustrative comparison for orientation only.

How Revelina compares

01

Injection force

Smooth, consistent extrusion feel.

02

Moulding strength

Holds its sculpted shape after placement.

03

Stability

Resists degradation for lasting correction.

04

Safety

Purity, ultra-low residual BDDE, tolerability.

05

Convenience

Ready-to-use with predictable handling.

06

Viscoelasticity

Balanced elasticity for a natural result.

Filler B / C / D denote anonymised market references; axis values are representative and do not constitute a head-to-head clinical claim.

Specifications

Line specifications

	FINE	DEEP	SUB-Q
HA Concentration	24 mg/mL	24 mg/mL	24 mg/mL
Lidocaine	3 mg/mL	3 mg/mL	3 mg/mL
Gel Texture	Dense Monophasic	Dense Monophasic	Dense Monophasic
Needle (incl. 2 ea)	30G × 13mm	27G × 13mm	25G × 13mm
Elasticity Level	+	+ +	+ + +
Viscoelasticity G′*	20–100 Pa	101–200 Pa	201–300 Pa
Depth of Injection	Superficial dermis	Mid-to-deep dermis	Deep dermis / subcutaneous
Indication	Fine lines, subtle volume	Mid-volume, contour	Structural lift, high-volume
Volume	1.0 mL	1.0 mL	1.0 mL

Each Box

1.0 mL pre-filled glass syringe ×1 · EO-sterilized single-use needles ×2 (line gauge) · Instructions for use.

*G′ values are reference estimates; actual values per OEM Certificate of Analysis. Needles are EO-sterilized, single-use. Duration of effect varies by individual, injection technique and area treated.

Line Characteristics

Viscoelasticity & gauge

How the three lines differ in elasticity and delivery.

Included needle gauge — 13 mm common

30G

13 mm · ×2

27G

13 mm · ×2

25G

13 mm · ×2

Bar thickness indicates relative needle bore (30G finest → 25G widest). EO-sterilized, single-use.

Technology

MCO™ Technology

Minimising Cross-linking agent by Optimising reaction.

The cross-linking agent connects HA chains into a stable network. By optimising the reaction conditions, MCO™ Technology maximises cross-linking efficiency while minimising the amount of residual cross-linking agent.

Revelina

viscosity & elasticity chart

Placement Guide

Injection site by line

Recommended placement across facial zones.

Schematic. Recommended placement only — area suitability is determined by the treating practitioner.

Manufacturing & Quality

Made by a specialist HA manufacturer

Revelina is produced by AQUABANK Inc., a licensed medical-device manufacturer specialising in HA-based dermal solutions, based in Seoul, Korea. Manufactured in a controlled Cleanroom Class 10,000 environment.

Certification

ISO 13485:2016

Medical Devices QMS · G-CERTI

License

MFDS Manufacturing

Manufacturing License (Korea)

Export

Free Sales

Certificate of Free Sales · MFDS · export-ready